NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/03/2025
Voltar para busca
Dado oficial do USPTO
UROVANT SCIENCES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
14/03/2025
Tipo de marca
Mista
Classes Nice
5, 38, 41, 44
Data de depósito
26/10/2021
Data de registro
03/01/2023
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/01/2023
Última transação
14/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
27
Localização do titular
CH
Examinador
WELCH, KATHERINE
Unidade examinadora
O20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "UROVANT". The letter "A" contains a wavy line design. Below the "VANT" is the word "SCIENCES" in a smaller font.
Titulares e representantes
Titulares
Urovant Sciences GmbH
Representantes
Jeffrey R. Cadwell Dorsey & Whitney LLP
Classificação técnica
Classes Nice
Classe 5Classe 38Classe 41Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and biological preparationsfor the prevention of urologicalurinary tract systemsreproductive organ diseases and disorders; pharmaceutical preparations for human use for the prevention of urologicalurinary tract systemsreproductive organ diseases and disorders; biological and pharmaceutical preparations for medical and therapeutic use for the prevention of urologicalurinary tract systemsreproductive organ diseases and disorders; pharmaceutical preparations for human use for the prevention of medical conditionsurologicalurinary tract system and reproductive organ disorders; pharmaceutical preparations for human use for the treatment of medical conditionsurologicalurinary tract system and reproductive organ disorders; biological and pharmaceutical preparations for medical and therapeutic use for the prevention of medical conditionsurologicalurinary tract system and reproductive organ disorders; biological and pharmaceutical preparations for medical and therapeutic use for the treatment of medical conditionsurologicalurinary tract system and reproductive organ disorders
Classe 38
Providing online chat rooms for transmission of messages among computer users concerning disease preventionidentification and treatment education relating to medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases; peer-to-peer network computer serviceselectronic transmission of audio sequencesvideo sequences as well as other data and documents among computerssuch audio sequencesvideo sequences and other data and documents all relating to preventionidentification and treatment of medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases; providing online chat rooms for transmission of messages among computer users concerning the fields of biological and pharmaceutical preparations; peer-to-peer network computer serviceselectronic transmission of audio sequencesvideo sequences as well as other data and documents among computerssuch audio sequencesvideo sequences and other data and documents all relating to the fields of biological and pharmaceutical preparations
Classe 41
Providing educational information in the academic fields relating to preventionidentification and treatment of diseases related to medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases for the purpose of academic study; providing educational information in the academic fields of biological and pharmaceutical preparations for the prevention of medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases for the purpose of academic study; providing educational information in the fields of preventionidentification and treatment of medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases for medical purposes; educational and entertainment servicesproviding motivational and educational speakers in the fields of medicinehealthpharmaceuticalsdisease and disorder identificationtreatment and prevention; providing online non-downloadable articles in the fields of medicinehealthpharmaceuticals and disease and disorder identificationtreatment and prevention
Classe 44
Provision of health information and medical informationall for treatment and diagnostic purposes; provision of information concerning the diagnosticprophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseasesconditionsdisorders and pathologies; providing health care advice and medical advice in the fields of preventionidentification and treatment of medical conditionsas well as urologicalmetabolicurinary tract systembladder and reproductive organ pathologiesdisorders and diseases; providing medical and physical health advice in the fields of biological and pharmaceutical preparations for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2024
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
12/04/2024
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
12/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/04/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
08/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/04/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/02/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/05/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
20/04/2023
FIMP
FINAL DISPOSITION PROCESSED
20/04/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/04/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
18/03/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/01/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/01/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/10/2022
PUBO
PUBLISHED FOR OPPOSITION
18/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/08/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/04/2022
RFNT
REFUSAL PROCESSED BY IB
18/04/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/03/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
28/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/03/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/03/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/03/2022
RFRR
REFUSAL PROCESSED BY MPU
25/03/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/02/2022
CNRT
NON-FINAL ACTION WRITTEN
18/02/2022
DOCK
ASSIGNED TO EXAMINER
11/02/2022
MAFR
APPLICATION FILING RECEIPT MAILED
25/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/01/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UROVANT SCIENCES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.